Clinical Trial Update: Neoadjuvant Chemotherapy Plus/Minus Surgery in Non-Small-Cell Lung Cancer (NSCLC) Stage IIIA/N2 [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study evaluating neoadjuvant chemotherapy with or without surgery for stage IIIA/N2 non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• neoadjuvant chemotherapy

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Non-Small Cell Lung Cancer | Phase 3 | Status: UNKNOWN